We found that six RBPs, including CMSS1, MAEL, THOC5, PSIP1, SNIP1, and ZCCHC7, are significantly related to OS of DLBCL patients, which could potentially be served as prognostic biomarkers. This evidence concerns the gene PSIP1 and diffuse large B-cell lymphoma.